At a glance
ClinicalIndex Comparison RecordN/ACompleted· 28 enrolled
Drug / intervention
Hyalistil Bio PFdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multicentric Clinical Investigation on the Use of Single-dose Ophthalmic Solution Based on Hyaluronate Sodium Phosphate in the Treatment of Eye Discomfort in Particular in Case of Ocular Dryness
In Brief
An observational study evaluating Hyalistil Bio PF for Ocular Dryness. Completed, enrolled 28 participants across 2 sites.
Detailed Summary
The purpose of this study is to assess the performance and safety resulting from the treatment of an ophthalmic solution for the ocular discomfort and in particular in presence of ocular dryness.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsOcular Dryness
CountriesItaly
Collaborators--
Timeline
N/ACompletedFinished
202420252026
Enrollment StartMar 2023
First PostedMar 2023
Primary CompletionAug 2023
TodayJul 2026
First PostedMar 21, 2023
Enrollment StartMar 14, 2023
Primary CompletionAug 3, 2023
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 3.3 years ago
Interventions
Hyalistil Bio PFdevice
Moisturizing and lubricating ophthalmic solution